​

Belite Bio Ownership | Who Owns Belite Bio?

OverviewForecastFinancialsChartTranscripts

Belite Bio Ownership Summary

Belite Bio is owned by 0.48% institutional investors, 53.93% insiders, and 45.60% retail investors. State street is the largest institutional shareholder, holding 0.07% of BLTE shares. SPDR® Portfolio Emerging Markets ETF is the top mutual fund, with 0.03% of its assets in Belite Bio shares.

BLTE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBelite Bio0.48%53.93%45.60%
SectorHealthcare Stocks 279.18%10.62%-189.80%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
State street20.02K0.07%$1.26M
Jpmorgan chase14.64K0.05%$923.53K
Ubs group12.21K0.04%$770.26K
Geode capital management6.70K0.02%$422.77K
Rhumbline advisers1.44K0.00%$90.55K
Gamma investing1.29K0.00%$81.40K
Morgan stanley1.04K0.00%$47.69K
Bank of america corp /de/102.000.00%$4.66K
Mirae asset global investments---
Point72 asset management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Gamma investing1.29K0.01%$81.40K
Rhumbline advisers1.44K0.00%$90.55K
Jpmorgan chase14.64K0.00%$923.53K
Ubs group12.21K0.00%$770.26K
Mirae asset global investments---
Bank of america corp /de/102.00-$4.66K
Point72 asset management---
Pnc financial services group---
Advisors preferred---
Advisor group7.00-$442.00

Top Buyers

HolderShares% AssetsChange
Ubs group12.21K0.00%12.08K
Jpmorgan chase14.64K0.00%8.28K
Gamma investing1.29K0.01%419.00
Rhumbline advisers1.44K0.00%-
Geode capital management6.70K--

Top Sellers

HolderShares% AssetsChange
Armistice capital---167.93K
Xtx topco---7.06K
Goldman sachs group---6.33K
Marshall wace, llp---5.87K
Hrt financial lp---5.41K

Sold Out

HolderChange
Pnc financial services group-8.00
Quantbot technologies lp-11.00
Mirae asset global investments-357.00
Advisors preferred-798.00
Virtus etf advisers-1.12K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202518-14.29%149,657-47.01%-56.18%12-14.29%5-
Dec 31, 20242140.00%282,406258.84%-1398.99%1427.27%5150.00%
Sep 30, 20241536.36%78,699-57.82%-64.88%11175.00%2-66.67%
Jun 30, 202410-9.09%186,140220.31%-1489.38%350.00%6-25.00%
Mar 31, 202411-35.29%58,112-62.53%-63.65%2-86.67%8700.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
SPDR® Portfolio Emerging Markets ETF10.57K0.03%-
SPDR® S&P Emerging Markets Small Cap ETF7.67K0.02%-
Fidelity Nasdaq Composite Index6.70K0.02%-
Fidelity Nasdaq Composite ETF6.13K0.02%-
Virtus LifeSci Biotech Clinical Trls ETF1.79K0.01%-
SPDR® S&P China ETF1.41K0.00%-
Quantified Global Fund Investor798.000.00%798.00
CIBC US Broad Market Index768.000.00%-
JHVIT Total Stock Market Index I494.000.00%8.00
ActivePassive International Equity ETF410.000.00%-

BLTE Ownership FAQ

Who Owns Belite Bio?

Belite Bio shareholders are primarily institutional investors at 0.48%, followed by 53.93% insiders and 45.59% retail investors. The average institutional ownership in Belite Bio's industry, Biotech Stocks , is 63.96%, which Belite Bio falls below.

Who owns the most shares of Belite Bio?

Belite Bio’s largest shareholders are State street (20.02K shares, 0.07%), Jpmorgan chase (14.64K shares, 0.05%), and Ubs group (12.21K shares, 0.04%). Together, they hold 0.15% of Belite Bio’s total shares outstanding.

Does Blackrock own Belite Bio?

BlackRock is not among the top 10 institutional shareholders of Belite Bio.

Who is Belite Bio’s biggest shareholder by percentage of total assets invested?

Gamma investing is Belite Bio’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 1.29K Belite Bio shares, valued at 81.4K$.

Who is the top mutual fund holder of Belite Bio shares?

SPDR® Portfolio Emerging Markets ETF is the top mutual fund holder of Belite Bio shares, with 0.03% of its total shares outstanding invested in 10.57K Belite Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools